Industrial stabilizers caprylate and N-acetyltryptophanate reduce the efficacy of albumin in liver patients

Liver Transplantation

Volumn 17, Issue 6, 2011, Pages 705-709

  Stange, Jan ^a   Stiffel, Melanie ^a   Goetze, Anne ^a   Strube, Sabrina ^a   Gruenert, Juliane ^a   Klammt, Sebastian ^a   Mitzner, Steffen ^a   Koball, Sebastian ^a   Liebe, Stefan ^a   Reisinger, Emil ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; N ACETYLTRYPTOPHAN; OCTANOIC ACID;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SOCIOECONOMICS; TREATMENT INDICATION;

AGED; ALBUMINS; BLOOD VOLUME; CAPRYLATES; CHARCOAL; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERTENSION, PORTAL; INFUSIONS, INTRAVENOUS; KIDNEY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 79957759300     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22237     Document Type: Article

References (18)

1. Kim WR, Gross JB, Poterucha JJ, Locke GR, Dickson ER., Outcome of hospital care of liver disease associated with hepatitis C in the United States. HEPATOLOGY 2001; 33: 201-206. (Pubitemid 32016903)
2. Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002-1010. (Pubitemid 26327603)
3. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-Del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-409. (Pubitemid 29362513)
4. Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. HEPATOLOGY 2002; 36 (4 Pt 1): 941-948.
5. SAFE Study Investigators, Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the Saline Versus Albumin Fluid Evaluation (SAFE) study. BMJ 2006; 333: 1044.
6. Kragh-Hansen U., Structure and ligand binding properties of human serum albumin. Dan Med Bull 1990; 37: 57-84.
7. Klammt S, Mitzner S, Stange J, Brinkmann B, Drewelow B, Emmrich J, et al. Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by Model for End-Stage Liver Disease. Eur J Gastroenterol Hepatol 2007; 19: 257-263.
8. Klammt S, Koball S, Hickstein H, Gloger M, Henschel J, Mitzner S, et al. Increase of octanoate concentrations during extracorporeal albumin dialysis treatments. Ther Apher Dial 2009; 13: 437-443.
9. Department of Health and Human Services. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Fed Regist 2000; 65: 52017.
10. Ishola DA Jr, Post JA, van Timmeren MM, Bakker SJ, Goldschmeding R, Koomans HA, et al. Albumin-bound fatty acids induce mitochondrial oxidant stress and impair antioxidant responses in proximal tubular cells. Kidney Int 2006; 70: 724-731. (Pubitemid 44215348)
11. Hassanein TI, Hilsabeck RC, Perry W., Introduction to the Hepatic Encephalopathy Scoring Algorithm. Dig Dis Sci 2008; 53: 529-538. (Pubitemid 351170035)
12. Rowley H, Collins RC., [1-14C]Octanoate: a fast functional marker of brain activity. Brain Res 1985; 335: 326-329. (Pubitemid 15074544)
13. Endo Y., In vivo deacetylation of N-acetyl amino acids by kidney acylases in mice and rats. A possible role of acylase system in mammalian kidneys. Biochim Biophys Acta 1980; 628: 13-18.
14. Ono J, Hutson DG, Dombro RS, Levi JU, Livingstone A, Zeppa R., Tryptophan and hepatic coma. Gastroenterology 1978; 74 (2 Pt 1): 196-200. (Pubitemid 8275634)
15. Carpenedo R, Mannaioni G, Moroni F., Oxindole, a sedative tryptophan metabolite, accumulates in blood and brain of rats with acute hepatic failure. J Neurochem 1998; 70: 1998-2003. (Pubitemid 28207823)
16. Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, et al. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 2010; 16: 279-286.
17. Kragh-Hansen U., Octanoate binding to the indole- and benzodiazepine-binding region of human serum albumin. Biochem J 1991; 273 (Pt 3): 641-644.
18. Travares-Almeida I, Gulyassy PF, Depner TA, Jarrard EA., Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma. Biochem Pharmacol 1985; 34: 2431-2438. (Pubitemid 15063074)